A detailed history of James Investment Research Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, James Investment Research Inc holds 38,093 shares of ABBV stock, worth $6.69 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
38,093
Previous 38,985 2.29%
Holding current value
$6.69 Million
Previous $6.69 Million 12.5%
% of portfolio
0.88%
Previous 0.81%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $146,145 - $177,802
-892 Reduced 2.29%
38,093 $7.52 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $31,731 - $37,055
-205 Reduced 0.52%
38,985 $6.69 Million
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $232,378 - $264,773
-1,454 Reduced 3.58%
39,190 $7.14 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $213,968 - $240,978
-1,555 Reduced 3.68%
40,644 $6.3 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $72,539 - $83,974
-543 Reduced 1.27%
42,199 $6.29 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $5.66 Million - $7.05 Million
42,742 New
42,742 $5.76 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $295,438 - $340,241
2,043 Added 4.97%
43,169 $6.88 Million
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $310,920 - $372,875
2,248 Added 5.78%
41,126 $6.65 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $2.02 Million - $2.31 Million
15,019 Added 62.95%
38,878 $5.22 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $24,083 - $30,618
175 Added 0.74%
23,859 $3.65 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $292,071 - $362,378
-2,213 Reduced 8.55%
23,684 $3.84 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $13,106 - $16,583
122 Added 0.47%
25,897 $3.51 Million
Q3 2021

Oct 22, 2021

BUY
$106.4 - $120.78 $56,924 - $64,617
535 Added 2.12%
25,775 $2.78 Million
Q2 2021

Jul 26, 2021

BUY
$105.21 - $117.21 $255,660 - $284,820
2,430 Added 10.65%
25,240 $2.84 Million
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $2.3 Million - $2.53 Million
22,472 Added 6648.52%
22,810 $2.47 Million
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $2,495 - $3,368
-31 Reduced 8.4%
338 $36,000
Q3 2020

Oct 23, 2020

BUY
$85.91 - $100.83 $31,700 - $37,206
369 New
369 $32,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $9,329 - $11,925
-142 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$77.14 - $90.79 $954,761 - $1.12 Million
-12,377 Reduced 98.87%
142 $11,000
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $974,604 - $1.2 Million
12,519 New
12,519 $1.15 Million
Q3 2018

Oct 26, 2018

SELL
$88.91 - $98.84 $1.74 Million - $1.94 Million
-19,605 Closed
0 $0
Q2 2018

Jul 19, 2018

BUY
$89.78 - $106.23 $224,898 - $266,106
2,505 Added 14.65%
19,605 $1.82 Million
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $82,809 - $110,889
-900 Reduced 5.0%
17,100 $1.62 Million
Q4 2017

Jan 23, 2018

BUY
$89.56 - $98.21 $1.61 Million - $1.77 Million
18,000
18,000 $1.74 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.